Page 6 - Alembic Pharmaceuticals

Alembic Pharma Q3 net up 25% as US formulations business moderates

Consolidated total income rises 9% to Rs 1,316.86 crore

Alembic Pharma gets USFDA nod for pills to treat salt, water retention

Alembic Pharmaceuticals said it received approval from the US health regulator for Metolazone tablets, indicated for the treatment of salt and water retention caused by heart failure or kidney disease

Alembic Pharma gets tentative USFDA nod for breast cancer treatment drug

Drug firm Alembic Pharmaceuticals said it has received tentative approval from the US health regulator for Palbociclib capsules, used to treat a certain type of breast cancer

Samvat 2077: Investors must look for safety first, tone down expectations

Given the sharp volatility, it is preferable to stick to leaders or top-tier players across sectors as they consolidate their position and gain market share

Alembic Pharma's Q2 net profit up 35% at Rs 333 cr on strong domestic biz

Consolidated total income up 17.65 per cent at Rs 1,460.32 cr in Q2 of FY21 as against Rs 1.241.23 cr a year ago

Alembic Pharma reports 35% rise in net profit to Rs 333 cr for Sept quarter

The company had posted a net profit of Rs 246.27 crore for the corresponding period of the previous fiscal, Alembic Pharma said in a filing to BSE

Alembic Pharma JV gets USFDA nod for antifungal topical solution

Drug firm Alembic Pharmaceuticals said its joint venture firm Aleor Dermaceuticals has received final approval from the US health regulator for anti-fungal Tavaborole Topical Solution

Alembic Pharma gets USFDA nod for anti-viral drug Amantadine Hydrochloride

Drug firm Alembic Pharmaceuticals said it has received approval from the US health regulator for Amantadine Hydrochloride tablets, used for treatment of influenza A virus

Stock tips by Nilesh Jain of Anand Rathi: Buy Radico Khaitan, Shoppers Stop

The stock of Radico Khaitan has found the support of its rising trend line and has also formed a reversal candle on the daily chart

Alembic Pharma arm gets tentative USFDA nod for drug to treat hypertension

Alembic Pharmaceuticals said its subsidiary has received tentative approval from the US health regulator for Treprostinil injection indicated for the treatment of pulmonary arterial hypertension

Alembic Pharma Q1 PBT almost doubles to Rs 359 cr, income rises 40%

Company attributes the huge spike to a strong show in the international markets

Alembic Pharma shares gain 5% to hit a new high after robust Q1 earnings

The company reported a net profit of Rs 301 crore in Q1FY21, against Rs 124 crore in the year-ago quarter.

Aarti Drugs to Tata Comm: Earnings rise for 15 firms in Covid-19 economy

These companies reported an increase in revenue and/or profit before tax for the March quarter

Alembic Pharma sees domestic business growing in double digits this fiscal

Strong brand recall, an efficient sales force, a growing network of supportive doctors and timely product launches are the key catalysts for this business

Alembic Pharma gets USFDA nod for generic Adapalene gel for acne treatment

The product was indicated for the topical treatment of acne vulgaris in patients 12 years of age and older, Alembic Pharma said

Alembic Pharma hits new high, surges 45% in 4 weeks on strong Q4 results

In the past four weeks, Alembic Pharma outperformed the market by surging 41 per cent as compared to Sensex's 1.1 per cent gain

Alembic Pharma hits 52-wk high, rallies 20% in 3 days on robust Q4 numbers

The stock is close to its all-time high level of Rs 792, hit in July 2015

Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month

Last week, the stock hit a fresh 52-week high of Rs 706 on the BSE

Alembic gets USFDA approval for generic doxycycline hyclate tablets

Doxycycline hyclate tablets are indicated for use as an adjunct to scaling and root planing to promote attachment level gain and to reduce pocket depth in patients

Alembic Pharma's Aleor Dermaceuticals gets USFDA nod for generic product

Alembic now has a cumulative total of 118 ANDA approvals from the USFDA